Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Upkar S Gill

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Med (New York, N.Y.)|January 24, 2022
Differential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipientsNicholas Kim Huat Khoo, Joey Ming Er Lim, Upkar S Gill, et al.
Nature Medicine|May 12, 2015
Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cellsLaura J Pallett, Upkar S Gill, Alberto Quaglia, et al.
The Journal of Clinical Investigation|January 9, 2018
Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuationLaura Rivino, Nina Le Bert, Upkar S Gill, et al.
The Journal of Experimental Medicine|May 21, 2017
IL-2<sup>high</sup> tissue-resident T cells in the human liver: Sentinels for hepatotropic infectionLaura J Pallett, Jessica Davies, Emily J Colbeck, et al.
Journal of Hepatology|June 23, 2025
Rapid whole-blood immune profiling reveals heterogeneous HBV-specific T cell response patterns independent of clinical disease phasesNina Le Bert, Apostolos Koffas, Rajneesh Kumar, et al.
Gastroenterology|April 18, 2020
Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infectionNina Le Bert, Upkar S Gill, Michelle Hong, et al.
Plos Pathogens|June 27, 2014
Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liverJuandy Jo, Anthony T Tan, James E Ussher, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell linesJonida Kokiçi, Helena Arellano-Ballestero, Benjamin Hammond, et al.
Cytotherapy|December 9, 2025
Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell linesJonida Kokiçi, Helena Arellano-Ballestero, Benjamin Hammond, et al.
Hepatology (Baltimore, Md.)|April 30, 2024
HIV/HBV coinfection remodels the immune landscape and natural killer cell ADCC functional responsesBo Sun, Kelly A S da Costa, Aljawharah Alrubayyi, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Med (New York, N.Y.)|January 24, 2022
Differential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipientsNicholas Kim Huat Khoo, Joey Ming Er Lim, Upkar S Gill, et al.
Nature Medicine|May 12, 2015
Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cellsLaura J Pallett, Upkar S Gill, Alberto Quaglia, et al.
The Journal of Clinical Investigation|January 9, 2018
Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuationLaura Rivino, Nina Le Bert, Upkar S Gill, et al.
The Journal of Experimental Medicine|May 21, 2017
IL-2<sup>high</sup> tissue-resident T cells in the human liver: Sentinels for hepatotropic infectionLaura J Pallett, Jessica Davies, Emily J Colbeck, et al.
Journal of Hepatology|June 23, 2025
Rapid whole-blood immune profiling reveals heterogeneous HBV-specific T cell response patterns independent of clinical disease phasesNina Le Bert, Apostolos Koffas, Rajneesh Kumar, et al.
Gastroenterology|April 18, 2020
Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infectionNina Le Bert, Upkar S Gill, Michelle Hong, et al.
Plos Pathogens|June 27, 2014
Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liverJuandy Jo, Anthony T Tan, James E Ussher, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell linesJonida Kokiçi, Helena Arellano-Ballestero, Benjamin Hammond, et al.
Cytotherapy|December 9, 2025
Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell linesJonida Kokiçi, Helena Arellano-Ballestero, Benjamin Hammond, et al.
Hepatology (Baltimore, Md.)|April 30, 2024
HIV/HBV coinfection remodels the immune landscape and natural killer cell ADCC functional responsesBo Sun, Kelly A S da Costa, Aljawharah Alrubayyi, et al.
Pageof 6